Human Milk Oligosaccharides (HMOs) Market to Reach $1.71 Billion by 2032
Meticulous Research®—a
leading global market research company, published a research report
titled ‘Human Milk Oligosaccharides (HMOs) Market—Global
Opportunity Analysis and Industry Forecast (2025-2032)’. According to this
latest publication, the human milk oligosaccharides (HMOs) market is expected
to reach $1.71
billion by 2032, at a CAGR of 21.2% from 2025 to 2032.
The human milk
oligosaccharides (HMOs) market is experiencing growth driven by increasing
demand for infant nutrition, a surge in dietary supplement consumption, growing
awareness of the benefits of HMOs, and enhanced product innovation by various
manufacturers. However, the high cost of HMOs and the availability of
alternative oligosaccharides in the market may hinder this growth.
Moreover, ongoing
technological advancements and government approvals for the use of HMOs in
human consumption present significant opportunities for market participants.
However, the market also encounters considerable challenges, including complex
production processes and stringent regulatory requirements. Conversely, the
growing trend toward clean-label products is becoming increasingly prominent
within the human milk oligosaccharides (HMOs) market.
Key Players:
The human milk
oligosaccharides (HMOs) market is characterized by a moderately competitive
scenario due to the presence of many large- and small-sized global, regional,
and local players. The key players operating in the human milk oligosaccharides
(HMOs) market are Chr. Hansen A/S (A part of Novonesis) (Denmark),
DSM-Firmenich AG (Switzerland), Kyowa Hakko Europe GmbH (Germany), Royal
FrieslandCampina N.V. (Netherlands), ZuChem Inc. (U.S.), ELICITYL S.A.
(France), Dextra Laboratories Limited (U.K.), Glycosyn LLC (U.S.), Nestle
Health Science (U.S.), Biosynth Ltd (U.K.), Inbiose NV (Belgium), BASF SE
(Germany), and Abbott Laboratories (U.S.), among others.
The human milk
oligosaccharides (HMOs) market is segmented based on type, concentration, and
application. The report also evaluates industry competitors and analyzes the
human milk oligosaccharides (HMOs) market at the regional and country levels.
By type, the 2’FL segment is expected to account for
the largest share of the human milk oligosaccharides market in 2025. This
segment’s substantial market share can be attributed to its robust product
availability since its approval in 2016, the increasing preference for HMOs
driven by their extensive health benefits and diverse applications, the
heightened demand for HMO-enriched infant formulas, and the rising integration
of 2'FL into these infant formula products.
By concentration, the neutral segment is expected to account
for the largest share of the human milk oligosaccharides (HMOs) market in 2025.
This segment's large market share is attributed to the high utilization of
neutral HMOs, including 2’FL, and the high approval of neutral products in
various countries for incorporation in infant formulas. Also, neutral HMOs have
prebiotic effects that enhance gut health and support the immune system in
infants.
By application, the infant formula segment is expected to
account for the largest share of the human milk oligosaccharides market in
2025. The large market share of this segment is attributed to the rising demand
for working professional women for their newborn babies, the growing
incorporation of HMOs by various infant nutrition manufacturers, and the
launching of various innovative products. Moreover, increasing awareness
regarding the use of HMOs for infant nutrition, including defending infants
from infections, enhancing their memory, promoting prebiotic effects,
supporting brain development, and maintaining gut health, further supports the
growth of the market.
This research report
analyzes major geographies and provides a comprehensive analysis of North
America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain,
Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, South
Korea, Australia, Indonesia, Malaysia, and Rest of Asia-Pacific), Latin America
(Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East
& Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East &
Africa).
By geography, North America is expected to account for
the largest share of the human milk oligosaccharides market in 2025, followed
by Asia-Pacific, Europe, Latin America, and the Middle East & Africa. The
significant share of this regional market can be attributed to several key
factors, including heightened awareness of the nutritional benefits of HMOs,
increasing consumer demand for HMO-based products, a rising trend toward
personalized nutrition with an emphasis on gut health, advancements in
technology within the region, and strong governmental support for regulatory
frameworks and policies.
Download Sample
Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6065
Key Questions
Answered in the Report-
- What is the value of revenue generated by
the sale of human milk oligosaccharides (HMOs)?
- At what rate is the global demand for
human milk oligosaccharides (HMOs) projected to grow for the next five to
seven years?
- What is the historical market size and
growth rate for the human milk oligosaccharides (HMOs) market?
- What are the major factors impacting the
growth of this market at global and regional levels?
- What are the major opportunities for
existing players and new entrants in the market?
- Which type, concentration, and application
segments create major traction for the manufacturers in this market?
- What are the key geographical trends in
this market? Which regions/countries are expected to offer significant
growth opportunities for the manufacturers operating in the human milk
oligosaccharides (HMOs) market?
- Who are the major players in the human
milk oligosaccharides (HMOs) market? What are their specific product
offerings in this market?
- What recent developments have taken place
in the human milk oligosaccharides (HMOs) market? What impact have these
strategic developments created on the market?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment